Artiva Biotherapeutics, Inc. ARTV Total Operating Expenses
Total Operating Expenses at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s total operating expenses?
- Artiva Biotherapeutics, Inc. (ARTV) reported total operating expenses of $24.43M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s total operating expenses changed year-over-year?
- Artiva Biotherapeutics, Inc.'s total operating expenses increased by 10.2% year-over-year, from $22.17M to $24.43M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s total operating expenses?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s total operating expenses has grown at a 18.3% compound annual growth rate (CAGR), from $64.16M to $89.81M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.